Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 15;7(8):2258-65.
eCollection 2014.

Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors

Nilüfer Aygün Bilecik  1 , Serpil Tuna  1 , Nehir Samancı  1 , Nilüfer Balcı  1 , Halide Akbaş  2
Affiliations

Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors

Nilüfer Aygün Bilecik et al. Int J Clin Exp Med. .

Abstract

Purpose: Metabolic syndrome (MS), which is framed by cardiovascular risk factors such as hypertension, obesity, glucose intolerance and dyslipidemia, is thought to be associated with the rheumatic diseases. The aim of this study is to examine the frequency of metabolic syndrome (MS) and insulin resistance in patients with rheumatoid arthritis (RA) and to examine the effect of the inflammation symptoms, disease activity and drugs used in treating RA on insulin resistance and presence MS.

Method: One hundred women patients diagnosed with RA according to the American College of Rheumatology (ACR) diagnosis criteria and 100 healthy women were included in the study as controls. Insulin resistance were evaluated using the homeostasis model assessment for insulin resistance (HOMA-IR) method and MS was diagnosed according to two Metabolic Syndrome definitions (National Cholesterol Education Programme 2004, International Diabetes Federation). The disease activity of RA was evaluated by the disease activity score including 28 joints (DAS28).

Results: In total, 27% and 33% of the RA patients and 28% and 44% of the control group patients according to the diagnostic criteria used were also MS patients. There was no significant difference between the RA and control groups in MS frequency and insulin resistance according to two diagnostic criteria used. The DAS28, erythrocyte sedimentation speed (ESS) and serum uric acid levels in the RA patients with MS were significantly higher than those of the RA patients without MS. The prevalence of MS İn patients with RA using methotrexate (MTX) was significantly lower than without RA. Other drugs used in treatment of RA had no effect on the prevalence of MS in patients with RA.

Conclusion: Controlling inflammation and disease activity can reduce the MS frequency of RA patients and MTX treatment also may be a protective factor against MS.

Keywords: HOMA-IR; MTX; Metabolic syndrome; insulin resistance; rheumatoid arthritis.

PubMed Disclaimer

References

    1. Henry RR. Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetes. Clin Ther. 2003;25(Suppl B):B47–63. - PubMed
    1. Masharani U, Germen MS. Pancreatic hormones and diabetes mellitus. In: Greenspan FS, editor. Basic and Clinical Endocrinology. The McGraw-Hill Companies. 7th edn. New York: 2004. pp. 646–658.
    1. Ferraz-Amaro I, Gonzalez-Juanatey C, Lopez-Mejias R, Riancho-Zarrabeitia L, Gonzalez-Gay MA. Metabolic syndrome in rheumatoid arthritis. Mediators of Inflammation. 2013:710928. - PMC - PubMed
    1. Symmons DP. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol. 2002;16:707–722. - PubMed
    1. Bacon PA. Arthritis and Allied Conditions. 13th edn. vol 71. Pennsylvania: Williams and Wilkins; Extra-articular rheumatoid arthritis.

LinkOut - more resources